(Q79264742)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Catherine Uyttenhove

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jacques Van Snick

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

2868-2874

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Cytokine vaccination: neutralising IL-1alpha autoantibodies induced by immunisation with homologous IL-1alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Vaccination with CD20 peptides induces a biologically active, specific immune response in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Therapeutic antibodies elicited by immunization against TNF-alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Knocking out IL-6 by vaccination.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Increased expression of interleukin 17 in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636662

7 January 2021

Identifiers

DOI

10.1002/EJI.200636662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17048276%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference